Market Cap | 6.95B | P/E | 24.76 | EPS this Y | 15.10% | Ern Qtrly Grth | 24.80% |
Income | 409M | Forward P/E | 19.10 | EPS next Y | 11.20% | 50D Avg Chg | 7.00% |
Sales | 5.07B | PEG | 1.45 | EPS past 5Y | 4.19% | 200D Avg Chg | 16.00% |
Dividend | 1.00% | Price/Book | 4.68 | EPS next 5Y | 15.76% | 52W High Chg | -2.00% |
Recommedations | 1.50 | Quick Ratio | 1.07 | Shares Outstanding | 100.63M | 52W Low Chg | 54.00% |
Insider Own | 1.43% | ROA | 8.09% | Shares Float | 99.17M | Beta | 0.78 |
Inst Own | 98.43% | ROE | 23.11% | Shares Shorted/Prior | 1.16M/1.53M | Price | 69.32 |
Gross Margin | 41.32% | Profit Margin | 7.88% | Avg. Volume | 550,200 | Target Price | 102.73 |
Oper. Margin | 16.57% | Earnings Date | Oct 24 | Volume | 1,875,256 | Change | 5.09% |
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.
RBC Capital | Outperform | Sep 26, 24 |
UBS | Buy | Sep 25, 24 |
Truist Securities | Buy | Aug 15, 24 |
UBS | Buy | Aug 8, 24 |
Stephens & Co. | Overweight | Aug 6, 24 |
Barclays | Overweight | Aug 6, 24 |
Truist Securities | Buy | Jul 15, 24 |
Barclays | Overweight | Jul 10, 24 |
Leerink Partners | Outperform | Jul 10, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
COLTHARP DOUGLAS E | EVP & Chief Financia.. EVP & Chief Financial Officer | Nov 13 | Sell | 63.39 | 11,215 | 710,919 | 116,293 | 11/14/23 |
COLTHARP DOUGLAS E | EVP & Chief Financia.. EVP & Chief Financial Officer | Nov 13 | Option | 26.55 | 16,623 | 441,341 | 127,508 | 11/14/23 |
Charbonneau Elissa Joy | Chief Medical Office.. Chief Medical Officer | Aug 17 | Sell | 69.58 | 8,294 | 577,097 | 23,081 | 08/18/23 |
Tarr Mark J | President & CEO President & CEO | Aug 16 | Sell | 71.06 | 25,330 | 1,799,950 | 497,405 | 08/17/23 |
Tarr Mark J | President & CEO President & CEO | Aug 16 | Option | 26.55 | 25,330 | 672,512 | 522,735 | 08/17/23 |
Tarr Mark J | President & CEO President & CEO | Aug 17 | Option | 20.07 | 20,449 | 410,411 | 461,344 | 08/19/22 |
Tarr Mark J | President & CEO President & CEO | Aug 17 | Sell | 53.25 | 20,449 | 1,088,909 | 440,895 | 08/19/22 |
COLTHARP DOUGLAS E | EVP & Chief Financia.. EVP & Chief Financial Officer | Feb 08 | Option | 21.02 | 26,132 | 549,295 | 55,555 | 02/09/22 |